Increasing use of blood tests to detect prostate cancer is leading to overworked doctors. NTNU has now created an AI ...
A new study is set to investigate how AI could significantly improve doctors’ decisions regarding prostate cancer treatment. While diagnostic methods for the disease have become safer and more precise ...
A scan that makes prostate cancer cells “glow” could halve the number of men needing invasive biopsies, research suggests.
The UCLA trial is currently enrolling patients. Clinical trial compares two targeted radiation therapies for recurrent prostate cancer. New AI tool, ProCUSNet, detects prostate cancer more accurately ...
CLEVELAND, Ohio — When it comes to cancer, deciding on the best course of treatment can sometimes feel like a coin toss. However, doctors at University Hospitals have a new tool that helps them weigh ...
Prostate cancer is the second-leading cause of cancer death in American men. About 1 in 8 men will be diagnosed with prostate cancer in their lifetime, and the risk varies depending on age and race.
Comparison of Patient-Reported Peripheral Neuropathy Among Patients Treated With Elranatamab Versus Real-World Clinical Practice in Triple-Class Refractory Multiple Myeloma To our knowledge, no ...
U.S. Senator John Boozman (R-AR) was recognized for his leadership in advancing policiies that prioritize enhanced care and research for prostate cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results